These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 16971232)

  • 1. Seroprevalence of hepatitis B and hepatitis C in patients with thalassemia and sickle cell anemia in a long-term follow-up.
    Ocak S; Kaya H; Cetin M; Gali E; Ozturk M
    Arch Med Res; 2006 Oct; 37(7):895-8. PubMed ID: 16971232
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Major risk of blood transfusion in hemolytic anemia patients.
    Omar N; Salama K; Adolf S; El-Saeed GS; Abdel Ghaffar N; Ezzat N
    Blood Coagul Fibrinolysis; 2011 Jun; 22(4):280-4. PubMed ID: 21508832
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevalence of anti HCV, HBsAg and HIV antibodies in high risk recipients of blood and blood products.
    Chakrabarti S; Pradhan P; Roy A; Hira M; Bandyopadhyay G; Bhattacharya DK
    Indian J Public Health; 2006; 50(1):43-4. PubMed ID: 17193761
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Seroprevalence of hepatitis B, hepatitis C, CMV and HIV in multiply transfused thalassemia patients: results from a thalassemia day care center in Malaysia.
    Jamal R; Fadzillah G; Zulkifli SZ; Yasmin M
    Southeast Asian J Trop Med Public Health; 1998 Dec; 29(4):792-4. PubMed ID: 10772566
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevalence and risk factors of hepatitis C virus, hepatitis B virus, and human immunodeficiency virus in multiply transfused recipients in Mexico.
    Calderón GM; González-Velázquez F; González-Bonilla CR; Novelo-Garza B; Terrazas JJ; Martínez-Rodríguez ML; Cortés-Márquez SR; Blanco-Flores JP; Rodríguez-Rodríguez A; Del Campo MA; Cortés-Gómez R; Mejía-Bocanegra MG
    Transfusion; 2009 Oct; 49(10):2200-7. PubMed ID: 19538543
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Sickle cell anemia and transfusion safety in Bamako, Mali. Seroprevalence of HIV, HBV and HCV infections and alloimmunization belonged to Rh and Kell systems in sickle cell anemia patients].
    Diarra AB; Guindo A; Kouriba B; Dorie A; Diabaté DT; Diawara SI; Fané B; Touré BA; Traoré A; Gulbis B; Diallo DA
    Transfus Clin Biol; 2013 Dec; 20(5-6):476-81. PubMed ID: 23916574
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Red cell alloimmunization and infectious marker status (human immunodeficiency virus, hepatitis B virus and hepatitis C virus) in multiply transfused thalassemia patients of North India.
    Makroo RN; Arora JS; Chowdhry M; Bhatia A; Thakur UK; Minimol A
    Indian J Pathol Microbiol; 2013; 56(4):378-83. PubMed ID: 24441225
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evidence of multiple hepatitis virus infections in autopsied materials of intravenous drug addicts.
    Schleicher S; Schieffer M; Jürgens S; Wehner HD; Flehmig B
    Ig Sanita Pubbl; 2005; 61(5):435-50. PubMed ID: 17214028
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Frequencies of hepatitis B, delta and human immune deficiency virus markers in multitransfused Saudi patients with thalassaemia and sickle-cell disease.
    el-Hazmi MA; Ramia S
    J Trop Med Hyg; 1989 Feb; 92(1):1-5. PubMed ID: 2918572
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Common transfusion-transmitted infectious agents among thalassaemic children in Bangladesh.
    Mollah AH; Nahar N; Siddique MA; Anwar KS; Hassan T; Azam MG
    J Health Popul Nutr; 2003 Mar; 21(1):67-71. PubMed ID: 12751676
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Assessment of the seroprevalence of viral hepatitis B, viral hepatitis C and HIV in multitransfused thalassaemia major patients in Karachi, Pakistan.
    Riaz H; Riaz T; Ullah F; Aziz S; Khan MU; Pervaiz R; Ejaz A; Hasan M; Moiz F; Naqvi SA
    Trop Doct; 2011 Jan; 41(1):23-5. PubMed ID: 20940290
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hepatitis B surface antigen, hepatitis C and HIV antibodies in a low-risk blood donor group, Nigeria.
    Egah DZ; Banwat EB; Audu ES; Iya D; Mandong BM; Anele AA; Gomwalk NE
    East Mediterr Health J; 2007; 13(4):961-6. PubMed ID: 17955779
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Seroprevalence of human immunodeficiency virus, hepatitis B virus and hepatitis C virus among eye donors.
    Mahalakshmi B; Madhavan HN; Pushpalatha R; Margarita S
    Indian J Ophthalmol; 2004 Mar; 52(1):61-2. PubMed ID: 15132383
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Viral hepatitis in Nigeria--sickle-cell disease and commercial blood donors.
    Mutimer DJ; Olomu A; Skidmore S; Olomu N; Ratcliffe D; Rodgers B; Mutimer HP; Gunson BK; Elias E
    QJM; 1994 Jul; 87(7):407-11. PubMed ID: 7922292
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Use of replacement blood donors to study the epidemiology of major blood-borne viruses in the general population of Maputo, Mozambique.
    Cunha L; Plouzeau C; Ingrand P; Gudo JP; Ingrand I; Mondlane J; Beauchant M; Agius G
    J Med Virol; 2007 Dec; 79(12):1832-40. PubMed ID: 17935167
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of blood transfusion on the prevalence of hepatitis C virus antibodies in children with sickle cell anaemia in Enugu, South East Nigeria.
    Ejiofor OS; Ibe BC; Emodi IJ; Ikefuna AN; Ilechukwu GC; Emechebe G; Ilechukwu C
    Niger J Clin Pract; 2009 Dec; 12(4):355-8. PubMed ID: 20329670
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevalence of markers for human immunodeficiency, hepatitis B and hepatitis C viruses in maxillofacial and oral surgery patients at Medunsa.
    Dreyer AF; Aspinall S; Jacobs FJ
    J Dent Assoc S Afr; 1993 Jul; 48(7):377-80. PubMed ID: 9511617
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Seroprevalence of hepatitis B and C virus infections among Lao blood donors.
    Jutavijittum P; Yousukh A; Samountry B; Samountry K; Ounavong A; Thammavong T; Keokhamphue J; Toriyama K
    Southeast Asian J Trop Med Public Health; 2007 Jul; 38(4):674-9. PubMed ID: 17883005
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antibody titration and immune response of Iranian beta-thalassemic patients to hepatitis B virus vaccine (booster effect).
    Azarkeivan A; Karimi G; Shaiegan M; Maghsudlu M; Tabbaroki A
    Pediatr Hematol Oncol; 2009 Jun; 26(4):195-201. PubMed ID: 19437322
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Multiple transfusions for sickle cell disease in the Democratic Republic of Congo: the importance of the hepatitis C virus.
    Batina Agasa S; Dupont E; Kayembe T; Molima P; Malengela R; Kabemba S; Andrien M; Lambermont M; Cotton F; Vertongen F; Gulbis B
    Transfus Clin Biol; 2010 Oct; 17(4):254-9. PubMed ID: 20961788
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.